Concentrix Corp — Director's Dealing 2022

Jul 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Concentrix Corp (CNXC)
CIK: 0001803599
Period of Report: 2022-07-01

Reporting Person: POLK DENNIS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-01	Common Stock	M	6389	$64.21	Acquired	24671	Direct
2022-07-01	Common Stock	M	3611	$48.14	Acquired	28282	Direct
2022-07-01	Common Stock	S	4099	$131.914	Disposed	24183	Direct
2022-07-01	Common Stock	S	2111	$132.908	Disposed	22072	Direct
2022-07-01	Common Stock	S	1100	$134.022	Disposed	20972	Direct
2022-07-01	Common Stock	S	1341	$134.90	Disposed	19631	Direct
2022-07-01	Common Stock	S	1349	$135.872	Disposed	18282	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-01	Employee Stock Option (Right to Buy)	$64.21	M	6389	Disposed	2027-10-03	Common Stock (6389.0)	Direct
2022-07-01	Employee Stock Option (Right to Buy)	$48.14	M	3611	Disposed	2028-04-09	Common Stock (3611.0)	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.46 to $132.43, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.49 to $133.45, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.49 to $134.46, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.64 to $135.63, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.65 to $136.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The stock option vested as to 20% of the shares on October 3, 2018, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

F8: The stock option vested as to 20% of the shares on October 3, 2018 and vests as to 1/60th of the shares monthly thereafter.